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HIV-associated nephropathy in African Americans. Human stage renal disease (ESRD) patients in patients with
immunodeficiency virus-1 (HIV-1) infection is associated with HIV-1 infection, and biopsy-proven HIV-associated FSGS.
several glomerular syndromes, the most prevalent of which is
Due to the potential for confusion, in this review theHIV-associated focal segmental glomerulosclerosis (FSGS). At
term HIV-associated FSGS will be used.present, HIV-associated FSGS may account for up to 30% of
patients in the United States entering end-stage renal disease HIV-associated FSGS may present with a range of
(ESRD) as a consequence of FSGS. The mechanisms responsible urine protein excretion, from low level proteinuria (2
for HIV-associated FSGS are not well defined, but evidence has
g/day) to severe nephrotic proteinuria. Nephrotic syn-been presented in favor of direct infection of renal parenchymal
drome is relatively uncommon, as is hypertension, al-cells and toxicity of HIV-1 accessory proteins. HIV-associated
FSGS has a striking predilection for patients of African descent. though either may occur. HIV-associated FSGS was ini-
This likely has a genetic basis, although the gene or genes tially noted to have propensity to progress to ESRD,
responsible have not yet been identified. One approach is to
often within six months. In the early days of the HIV-1examine candidate genes for polymorphisms that are associated
epidemic, the course of HIV-associated FSGS was notedwith disease. Another approach uses a genome-wide scan, rely-
ing upon linkage disequilibrium between DNA markers and to be unusually fast, often progressing to ESRD in
the disease gene, to identify the causal gene or genes. African months. In recent years, with the advent of highly active
Americans are an admixed population, with genetic contribu-
anti-retroviral therapy (HAART) and the widespreadtions from African, European, and Native American popula-
use of angiotensin antagonist therapy, the clinical picturetions. In admixed populations, linkage disequilibrium between
disease genes and marker genes can be exploited to identify has changed dramatically. With effective anti-retroviral
disease genes, using an approach termed mapping by admixture treatment, the renal disease often stabilizes, reverses,
linkage disequilibrium (MALD).
and may even disappear [3]. The number of patients in
the United States Renal Data Systems (USRDS) data-
base beginning ESRD due to AIDS nephropathy peakedHuman immunodeficiency virus-1 (HIV-1) infection
in 1995 and had declined slightly since, the timing consis-is associated with several glomerular syndromes, as first
tent with beneficial effects of HAART, which was intro-recognized in the mid-1980s (Table 1). Most common
duced in 1996.among European, Hispanic, and Asian patients are im-
The pathologic features of HIV-associated FSGS in-mune complex glomerulonephritis, with deposition of
clude segmental glomerulosclerosis or solidification. Theeither IgA or multiple immunoglobulins [1, 2]. Most
glomerular capillary tuft may show global or segmentalcommon in patients of African descent is focal segmental
capillary collapse; the latter may be a subtle finding thatglomerulosclerosis (FSGS), which affects approximately
is distinguished from solidification by the relatively scant10% of HIV-infected patients. The term HIV-associated
nephropathy has been used in different ways, including amount of periodic acid Schiff (PAS)-stained matrix pro-
describing all HIV-associated glomerular disease, end- tein. The podocytes are hyperplastic and may have prolif-
erated to form a pseudo-crescent. The tubular epithelium
shows focal flattening, atrophy, and formation of micro-1 The content of this publication does not necessarily reflect the views
or policies of the Department of Health and Human Services, nor does cysts. The interstitium frequently has edema and a mono-
mention of trade names, commercial products, or organizations imply nuclear infiltrate that may be out of proportion to theendorsement by the U.S. Government. The publisher or recipient
severity of glomerular involvement. Ultrastructurally,acknowledges right of the U.S. Government to retain a nonexclusive,
royalty-free license in and to any copyright covering the article. glomerular endothelial cells may manifest tubulore-
ticular inclusions, in common with lupus nephritis andKey words: viral infection, black Americans, focal segmental glomerulo-
sclerosis, toxic HIV-1 accessory proteins, admixed population, MALD. thought to represent the effects of cytokines (possibly
interferon-). 2003 by the International Society of Nephrology
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Table 1. HIV-associated glomerular disease with sufficient attention to renal disease. An autopsy
study from Texas suggested that 12% of African Ameri-Common
Focal segmental glomerulosclerosis can patients dying with HIV-1 infection have histologi-
Mesangial proliferative glomerulonephritis cally-confirmed FSGS; this is the best available estimateIgA nephropathy
of prevalence [7]. Further, while the number of HIVUncommon
Thrombotic microangiopathy deaths have been declining, the fraction of death certifi-
Membranoproliferative glomerulonephritis (typically associated cates that mention HIV and also mention renal diseasewith HCV co-infection)
is increasing [8]. In 1999, 10% of individuals (14% ofMembranous nephropathy
Amyloid blacks dying with HIV and 6% of whites dying with
HIV) had renal disease (mostly renal failure) as a co-
morbid condition. This places renal disease second only to
liver disease (11%) as an associated condition at the time
of death in HIV-infected patients. Thus, HIV-infected
EPIDEMIOLOGY patients are living longer and healthier lives, but the
The racial discrepancy in susceptibility to HIV-associ- prevalence of renal disease at the time of death continues
ated FSGS is quite striking, with patients of African to rise.
descent being at substantially increased risk as reported
in studies from the USA, France and Brazil [4, 5]. Similar
PATHOMECHANISMS: INFECTION OF CELLScomparative data are not available from Africa. Never-
Several lentiviruses are associated with FSGS, includ-theless, it is notable that reports from Zaire indicate
ing HIV-1 in human, simian immunodeficiency virusthat FSGS became the dominant cause of the nephrotic
(SIV) in monkey, and feline immunodeficiency virussyndrome in a study of renal biopsies performed between
(FIV) in cats. The mechanisms by which lentiviruses1986 and 1989, displacing minimal change disease and
induce glomerular injury eventuating the pathologic syn-amyloid, which had been the leading causes prior to the
drome of FSGS is not well understood, but several majorappearance of HIV-1 [6].
mechanisms can be considered.The USRDS database lists 849 patients who entered
First, there are scant data supporting opportunistic in-ESRD in 1999, the last year for which data are available,
fection as a cause of HIV-associated FSGS. Lo and col-with a diagnosis of AIDS nephropathy (a renal biopsy
leagues suggested that Mycoplasma fermentans was asso-is not required for this diagnosis). Of the 824 patients
ciated with FSGS [9]. We have presented data that SV40for whom race was known, 94% were African American
may contribute to FSGS in both HIV-infected and unin-and 6% were white. The CDC Division of HIV-AIDS
fected patients [10].Prevention indicates that as of December 1999, 412,471
Second, HIV-1 likely infects lymphocytes and macro-individuals were alive with HIV-1 infection. As of De-
phages that enter the kidney and might release inflam-cember 1999, a cumulative total of 733,374 patients had
been infected with HIV-1 and of these 38% were black, matory lymphokines, or cytokines, which promote injury
and fibrosis. This hypothesis has not been evaluated di-not Hispanic, and 43% were white, not Hispanic. From
these data, we estimate that the annual risk for ESRD rectly.
Third, there is a growing body of evidence that HIV-1due to AIDS nephropathy among African American pa-
tients is approximately 4945 per million HIV-1 infected may infect renal parenchymal cells and elicit a cytopathic
effect, including proliferation or apoptosis. In vitro ex-individuals, and among white patients is approximately
276 per million HIV-1 infected individuals per year. periments have demonstrated low level productive infec-
tion of cultured tubular epithelial cells [11]. Some investi-Thus, the relative risk for AIDS nephropathy is approxi-
mately 18-fold increased among African Americans. gators, but not others, have reported the infection of
mesangial cells [12–14]. Infection of human podocytesAssuming that all patients with AIDS nephropathy
have FSGS, then approximately 800 patients develop has not been described.
At the electron microscopic level, HIV-1 virions haveESRD due to HIV-associated FSGS each year in the
US. The USRDS data base indicates that approximately not been demonstrated within the kidney. On the other
hand, HIV-1 virions are also difficult to demonstrate in2000 patients each year enter ESRD due to non-HIV
associated FSGS (although this is likely an underesti- lymphoid tissue or in tissue macrophages, although they
are readily demonstrated in cultured lymphocytes in-mate, since many patients with FSGS likely enter ESRD
without a renal biopsy). Therefore, nearly 30% of FSGS fected experimentally. Thus, the failure to demonstrate
virions in the kidney may simply mean that infectionincident ESRD patients have HIV-1 infection as the cause.
True population-based estimates of the prevalence of occurs infrequently and is associated with low-level viral
replication.FSGS among African Americans with HIV-1 infection
are not available, as large cohorts have not been followed Localization of HIV-1 protein and RNA to renal pa-
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Table 2. HIV-transgenic mice with renal renal disease
Reference Promoter HIV genes Renal phenotype
Dickie et al [18] LTR env, tat, rev, nef, vif, vpr, vpu FSGS
Kimmel et al, (abstract)a LTR tat, rev, nef, vif, vpr, vpu FSGS
Kajiyama et al [19] LTR env, tat, rev, vif, vpr, vpu FSGS
Jolicoeur et al [20] CD4 nef Interstitial nephritis
Dickie et al (unpublished observations) LTR tat, vpr FSGS
a (abstract; Kimmel et al, J Invest Med 44:321A, 1996)
renchymal cells has been controversial. While Cohen et al future work: Tat is a transactivating protein that in-
creases production of viral RNA. Vpr (viral protein R)found both protein and RNA in podocytes and tubular
epithelial cells [15], others were unable to replicate these has multiple effects on host cells including G2 cell cycle
arrest, regulation of apoptosis and cytokine production,findings. Recently, Klotman and collaborators have de-
veloped sensitive in situ hybridization techniques and and acting as both a transcriptional co-activator and co-
repressor. Nef (originally named as a negative factorconfirmed the initial localization of viral RNA and provi-
ral DNA to podocyte and tubular epithelial cells [16]. for viral replication) functions to down-regulate CD4
expression. Recently, Tat has been shown to induce pro-Further, they have shown that podocytes have particular
variants, suggesting that renal infection may involve se- liferation in cultured podocytes, possibly by stimulating
release of basic fibroblast growth factor [22]. In summary,lection for certain genotypes, and that renal epithelial
cells may constitute a reservoir in patients receiving anti- in mice viral accessory proteins induce many of the char-
acteristic functional and histologic changes of HIV-asso-retroviral treatment [17].
ciated FSGS. An important future step will be to extend
these observations to human patients and to translate
PATHOMECHANISMS: TOXICITY OF HIV these insights into improved therapies for human patients.
ACCESSORY PROTEINS
A fourth pathomechanism involves toxicity of HIV-1
VIRAL GENETIC VARIATIONproteins. Experiments using transgenic mice have dem-
onstrated that particular HIV-1 accessory proteins can The transcription of HIV-1 viral RNA to proviral
DNA by viral reverse transcriptase and then to viralinduce FSGS and interstitial nephritis (Table 2), includ-
ing the features characteristic of HIV-associated FSGS, RNA by host RNA polymerase II is relatively error
prone, producing approximately 1 error for every 10,000such as focal and segmental capillary collapse and solidi-
fication of the glomerular capillary tuft, podocyte hyper- bp or one error per genome. Consequently, most virions
are defective, but this genomic plasticity facilitates rapidplasia (but not tubulo-reticular inclusions in glomerular
endothelial cells), microcystic tubular dilation, tubular viral evolution that enables the virus to evade host immu-
nologic defenses and overcome antiviral therapy. A largeatrophy, mononuclear interstitial infiltrate, proteinuria,
and progressive renal dysfunction culminating in ESRD. number of viral quasi-species have been partially or fully
sequenced. The env (envelope) gene encodes the trans-These transgenic mice do not produce virions, since the
gag and pol genes are lacking from the transgenes and, membrane glycoprotein gp41 and the associated glyco-
protein gp120. Env gp120 first binds CD4, which inducestherefore, in this model system a replicating virus is not
required to induce FSGS. Instead, these data point to a a conformational change in gp120 facilitating binding to
one of several chemokine co-receptor molecules. At leastdirect toxic effect of HIV proteins on renal cells. Two
lines of evidence suggest that local renal production of six chemokine co-receptors are known, and in certain
situations these may not require the presence of CD4.these proteins is critical: lines that do not express the
transgene in kidney but express the transgene in other Variations in the sequence of gp120 account for the abil-
ity of particular HIV-1 variants to infect lymphocytetissues do not develop renal disease [18], and renal dis-
ease follows the transgenic kidney in renal transplant cell lines and some primary lymphocytes by using the
chemokine receptor CXCR4 or macrophages and pri-experiments [21].
A provisional summary of the available data from the mary lymphocytes using CCR5. The receptors that are
responsible for viral entry into renal parenchymal cellstransgenic mice suggests that Tat or Vpr or both may
induce FSGS, and that Nef may contribute to interstitial have not been well characterized. CD4 has not been
convincingly demonstrated on any renal parenchymalnephritis (without being strictly required). These viral
proteins have complex effects on cell function and how cell in vivo, although RNA has been reported in cultured
renal tubular epithelial cells. Mesangial cell infection hasthese might induce renal injury is an exciting area for
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been proposed to be dependent on GPR1 [14]. It could sib-pair analyses are not feasible for the identification of
disease genes, population-based studies using a genome-be hypothesized that particular viral variants have muta-
tions in gp120 that either facilitate entry into renal cells, scan (indirect) or a candidate gene (direct) approach
provide viable alternative strategies. The detection ofor that mutations in other viral proteins have particular
toxicity for renal cells, but few data have been published polymorphic genes influencing common or low penetrant
diseases such as non-familial FSGS is the goal of popula-addressing this issue.
tion-based association studies [24–26].
Population-based association studies use distortions
HOST GENETIC VARIATION: APPROACHES
in allele or genotype frequencies between disease and
TO GENE IDENTIFICATION
control groups to detect disease genes, either by direct
As noted earlier in this article, subjects of African investigation of candidate genes or indirectly through
descent are at markedly increased risk for FSGS in the investigation of genetic markers that track the causative
setting of HIV-1 infection, with perhaps a 14-fold in- gene or genes [27]. For the direct gene approach, the
creased risk compared to Caucasians. Since a similar selection of candidate genes should be based on biologi-
predilection is seen in studies from the US, France, and cal insight that there may be a causal relationship be-
Brazil, cultural factors seem an unlikely explanation. In- tween the genetic factor and the disease. However, this
stead, it appears highly likely that one or more host approach will miss unknown or unidentified causative
genetic loci contributes, with particular risk alleles being genes. The indirect approach takes advantage of the
more common in patients of African descent. These al- nonrandom association (termed linkage disequilibrium)
leles might contribute to entry of HIV-1 into renal cells, that exists between alleles on the same ancestral chromo-
might potentiate the toxicity of HIV-1 accessory proteins somal segment. By carrying out a whole-genome scan,
in renal cells, or might heighten a fibrotic response to that is, genotyping DNA markers spaced at intervals
HIV-1 initiated renal injury. across the human genome, it is possible to detect associa-
The genetic mutation that contributes to HIV-associ- tions between the marker and the disease phenotype if
ated FSGS might possibly (1) be unique for HIV-associ- the genetic marker is in linkage disequilibrium with the
ated FSGS or (2) extend to idiopathic FSGS or (3) causative genetic factor [28]. This method has the sig-
extend to other forms of glomerular injury. There is no nificant advantage of identifying genes that were not
evidence that the first possibility is true, but the relative previously identified as likely candidates. Identifying
rarity of HIV-1 infection (0.2% of the US population previously unsuspected genetic factors is likely to reveal
is known to be infected) makes it difficult to estimate the unexpected mechanisms in disease pathogenesis.
risk for HIV-associated FSGS among different kindreds.
On the other hand, it has been reported that probands
ASSOCIATION STUDIESwith HIV-associated nephropathy have an increased num-
ber of first and second degree relatives with ESRD (but Candidate gene association studies compare the fre-
quency of genetic polymorphisms for particular candi-not necessarily FSGS) compared to ethnically-matched
relatives with HIV-1 infection but without kidney disease date genes between disease and control populations.
Such studies, while commonly employed, have several[23]. These data tend to support the second and especially
the third possibility noted above. Thus, HIV-associated potential pitfalls. First, the list of attractive candidate
genes is often quite long. Second, markers within orFSGS likely has a genetic component (or components)
and an environmental component (viral infection), so near the candidate gene may not have been discovered,
necessitating a lengthy search for polymorphisms in regu-that patients who do not develop HIV-1 infection are at
increased risk for other forms of glomerular injury. latory and coding regions of the candidate genes. Third,
multiple comparisons may lead to spurious associationsWhat strategies are available for identifying genetic
loci associated with complex diseases that may be both due to statistical fluctuations. Fourth, the choice of con-
trol populations is critical, as the disease and controlpolygenic and have an environmental component? Ap-
proaches using classic family studies are ideal for simple populations may have differences in substructure (subtle
differences in genetic background) that confound theMendelian disease phenotypes, particularly those having
high heritability and penetrance. However, family-based result and may lead to non-causal associations. Popula-
tion substructure can be minimized by careful matchinglinkage studies have a low chance of success with low
penetrant, multifactorial diseases. This is due both to of cases and controls for ethnicity and race, but the
theoretical possibility of substructure within an ethnic/the low number of affected individuals available in any
kindred and the likelihood of mis-assigning unaffected racial group remains. Fifth, even after a positive associa-
tion is discovered within a candidate gene, the possibilityindividuals who in fact have the high-risk alleles but have
not encountered the appropriate environmental stimu- remains that the association may result from linkage
disequilibrium between the candidate gene and the truelus. In situations where family-based linkage studies or
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causal gene it is tracking. If the causal gene and its marker only a small number of individuals survive to reproduce
(such as, population contraction following a lethal epi-are in complete linkage disequilibrium, it may be impos-
sible to determine the causal factor by genetic analysis demic), and evolutionary selection (for example, selec-
tion pressure for an allele of one gene would influencealone. Criteria for validating genetic associations include
the following: (1) replication in different study popula- the transmission of linked gene segments).
In most white populations, the extent of linkage dis-tions, (2) low statistical P values after correction for
multiple comparisons, (3) high relative hazard or risk, equilibrium is limited to blocks of linkage disequilibrium
of approximately 60 to 100 kb separated by small regionsand (4) functional data relating the genetic polymor-
phism to gene function and biological relevance with the of high recombination (recombination is the exchange of
genomic segments between sister chromosomes at eachdisease [29].
We have initiated studies comparing genetic polymor- meiosis) [30, 31]. The number of genetic markers required
to map by linkage disequilibrium is therefore daunting,phisms among the following groups: African Americans
with HIV-associated FSGS, African Americans with id- somewhere on the order of 30,000 to 50,000 SNPs would
be required for 0.1 centiMorgan (cM) (100 kb) coverage.iopathic FSGS, African Americans with HIV-1 infection
but without renal disease (a hyper-normal control group, Very recently, haplotype mapping has suggested that the
haplotype blocks are much larger and more stable thanin that these individuals have been challenged by a virus
known to induce FSGS but have not developed the syn- previously believed. Knowledge of haplotype structure
among populations will facilitate the selection of haplo-drome), African American blood donors, European
Americans with idiopathic FSGS, and European Ameri- type-specific SNP markers, thus increasing the resolution
and power to identify disease genes [32]. In Native Afri-can blood donors. We are in the process of genotyping
these subjects for a variety of candidate genes, including cans, the extent of linkage disequilibrium is much less
since the populations are older with more recombinationthose for chemokine receptors, chemokines, cytokines, and
members of the renin-angiotensin-transforming growth events, and therefore mapping by linkage disequilibrium
would be even more difficult [33, 34].factor- (TGF-) system. To date, the only gene to show
However, in recently admixed populations (such asdifferences between African American patients with
African Americans or Hispanic Americans), both simu-HIV-associated FSGS and African American control sub-
lation and empirical studies have shown that linkagejects is the angiotensin converting enzyme (ACE1) gene.
disequilibrium can extend over many cM before it isPatients homozygous for the insertion allele in intron 16
reshuffled by recombination [34, 35]. Theoretical calcula-are at increased risk for FSGS; this is true for African
tions suggest that sufficient linkage for mapping studiesAmericans with both HIV-associated FSGS and idio-
remains for 10 to 20 generations after admixture beganpathic FSGS (abstract; Kopp et al, J Am Soc Nephrol
[34]. If the ancestral populations have different genetic9:390A, 1998). Analysis is underway for European Ameri-
risks for a particular disease, linkage disequilibrium cancan subjects, but the insertion allele is common in Cauca-
be exploited to map the genes that underlie these risksian populations as well, and so while it is unlikely that
differentials.the ACE1 insertion/deletion is itself causal, it may be
The identification of genetic loci in admixed popula-tracking the another polymorphic site elsewhere in the
tion has been termed mapping by admixture linkageACE1 gene.
disequilibrium (MALD). In practical terms, successful
MALD requires a sufficiently large number of marker
LINKAGE DISEQUILIBRIUM MAPPING genes with allele frequencies that differ sufficiently be-
Linkage disequilibrium mapping is an indirect method tween the ancestral populations and are distributed at
of identifying causal disease genes based on linkage dis- approximately equal intervals across the genome [36].
equilibrium between a genetic marker and an adjacent Data analysis involves comparing the prevalence of
disease gene [27, 28]. When a disease gene mutation marker genes polymorphisms among the disease and
occurs, it is in complete linkage disequilibrium with all control groups, looking for distortions that identify a
flanking alleles. The rate of linkage disequilibrium decay particular genomic region in which there is a tendency
to equilibrium is a function of the distance between the for the disease population to inherit genes disproportion-
markers and elapsed time from the mutation event. Sev- ately from one ancestral population. Several approaches
eral processes tend to maintain or reintroduce linkage to testing for linkage disequilibrium have been proposed,
disequilibrium in human populations. These processes including transmission disequilibrium testing and a Bay-
include recent admixture between two racial groups or esian approach involving conditioning on parental ad-
populations (for example, admixture between Africans mixture [37, 38]. In the present example, this would mean
and Europeans), the founding of a new population by a a genomic segment that is disproportionately African in
small number of individuals (such as, the Polynesian ex- origin in African American patients with HIV-associated
FSGS compared to control African American subjects.plorers settling Hawaii), population bottle necks in which
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Diabetes and Digestive and Kidney Diseases, National Institutes ofThis approach is still in its infancy, and has not yet been
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